Expert Review of Hematology

Aims & Scope

Advanced molecular research techniques have transformed hematology in recent years.

With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation.

We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies.

Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care.

Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.1
2024	2.30

SJR (SCImago Journal Rank)

Year	Value
2024	0.724

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	58

Journal Rank

Year	Value
2024	7767

Journal Citation Indicator

Year	Value
2024	724

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Mitochondria and Iron: current questions

  Citation: 365

  Authors: Bibbin T., David H., Frank M., Suzy V.

• D-dimer level in COVID-19 infection: a systematic review

  Citation: 273

  Authors: Mehrdad, Hassan

• Relapse after allogeneic stem cell transplantation

  Citation: 161

  Authors: A John, Minoo

• Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders

  Citation: 158

  Authors: Roshan, Ajit, Anita

• Allogeneic hematopoietic cell transplantation: the state of the art

  Citation: 151

  Authors: Boglarka, Andrew, Rainer F

• An update on the biology and management of dyskeratosis congenita and related telomere biology disorders

  Citation: 148

  Authors: Marena R., Sharon A.

• High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review

  Citation: 133

  Authors: Theodore E.

• Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field

  Citation: 132

  Authors: Peter, Gerald J, Andreas, Florence, Peter F, Andrzej, Georgia, Kristin M, Michel, Karl, Joseph H, Sabine, Matthias, Peter, Torsten, Bruce S, Jason, Hans-Peter, Hans-Uwe, Amy D

• Akt signaling in platelets and thrombosis

  Citation: 123

  Authors: Donna S

• Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms

  Citation: 118

  Authors: Manli, N. Nora, Andrew L.

---